Literature DB >> 4821316

Childhood polymyositis. A follow-up study with special reference to treatment with corticosteroids.

A L Rose.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4821316     DOI: 10.1001/archpedi.1974.02110230064009

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


× No keyword cloud information.
  8 in total

Review 1.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  Treatment of dermatomyositis in childhood.

Authors:  V Dubowitz
Journal:  Arch Dis Child       Date:  1976-07       Impact factor: 3.791

3.  Tubular cytoplasmic inclusions in a case of childhood dermatomyositis with migratory subcutaneous nodules.

Authors:  S Kimura; Y Fukuyama
Journal:  Eur J Pediatr       Date:  1977-08-12       Impact factor: 3.183

4.  Drug treatment of juvenile dermatomyositis.

Authors:  G Miller; J Z Heckmatt; V Dubowitz
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

5.  Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

Authors:  A El-Ghobarey; G Balint; K de Ceulaer; W C Dick; W W Buchanan; T Hadidi; T A Hassan
Journal:  Postgrad Med J       Date:  1978-08       Impact factor: 2.401

6.  Prognosis and treatment of polymyositis with particular reference to steroid resistant patients.

Authors:  M Yoshioka; T Okuno; H Mikawa
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

7.  Juvenile dermatomyositis: medical, social and economic status in adulthood.

Authors:  A Chalmers; R Sayson; K Walters
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

8.  Juvenile dermatomyositis: a review.

Authors:  P Malleson
Journal:  J R Soc Med       Date:  1982-01       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.